Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ISRCTN13207472) titled 'A two-part study in healthy volunteers to investigate the feasibility of a combined test medicine formulation' on June 29.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Sequential
Purpose: Formulation development
Primary Sponsor: Evecxia Therapeutics Inc.
Condition:
Healthy volunteers
Other
Intervention:
In Part 1 volunteers receive reconstituted 5-HTP powder for oral solution alone in a sipping regimen split into 10 equal doses administered over 9 hours on one occasion, in combination with reconstituted carbidopa...